Fundraising Fox
LumaBridge
Founded 2013 · 14 employees on LinkedIn · 1 known investors
Find your way into LumaBridge
Sign up to see every warm intro you have to LumaBridge
- Paths you didn't know you had: your email and LinkedIn already hold routes to the LumaBridge team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
LumaBridge is an oncology-focused contract research organization (CRO) that supports outsourced clinical trials, offering services such as regulatory affairs, clinical operations, data management, medical writing, and biostatistics. It serves emerging biopharma and biotech companies developing novel oncology and immunotherapy treatments.
Founders & leadership
LumaBridge was founded in 2013 by George Peoples.
GP
George PeoplesFounderDr. George E. Peoples is a retired military surgical oncologist and founder of Cancer Insight, a clinical research organization specializing in oncology and immunotherapy that was rebranded as LumaBridge following a 2021 majority acquisition by Summit Partners and subsequently acquired by Avance Clinical in 2025. He previously served as Chief of Surgical Oncology at Walter Reed and Brooke Army Medical Centers and holds faculty positions at the Uniformed Services University of the Health Sciences and MD Anderson Cancer Center, with over 350 peer-reviewed publications on cancer immunotherapy.
Investors · 1
Related companies · 5
ADPADP provides cloud-based human capital management solutions that integrate payroll, HR, talent management, time and attendance, tax, and benefits administration for businesses globally. The company serves as a comprehensive provider of HCM software and business outsourcing services with analytics and compliance expertise.
BridgebioBridgeBio develops treatments for genetic conditions and cancers using a decentralized hub-and-spoke model, where autonomous teams focus on specific diseases or drug candidates while a central hub provides clinical, regulatory, and commercial support. The company partners with academic institutions to advance early-stage research toward late-stage clinical trials.
LumanityLumanity provides consulting services across strategy, evidence generation, stakeholder engagement, and technology and AI to support pharmaceutical and life sciences companies in bringing medicines to patients. It helps clients identify value inflection points to inform strategic decisions in drug development and commercialization.
ConsiderConsider is a recruiting platform that helps talent teams source and manage candidate profiles, including a Chrome extension for adding LinkedIn profiles to talent pools in one click. It offers recruiting analytics, SSO, and two-way integrations with tools such as Greenhouse, Lever, and Salesforce.
PreqinPreqin provides a data and intelligence platform for investment teams, M&A professionals, and corporate development teams to source, evaluate, and value private company investments through integrated asset, fund, and performance data.
Companies working in the same space as LumaBridge.
Frequently asked questions
- What does LumaBridge do?
- LumaBridge is an oncology-focused contract research organization (CRO) that supports outsourced clinical trials, offering services such as regulatory affairs, clinical operations, data management, medical writing, and biostatistics. It serves emerging biopharma and biotech companies developing novel oncology and immunotherapy treatments.
- Who founded LumaBridge?
- LumaBridge was founded by George Peoples in 2013.
- Who are LumaBridge's investors?
- LumaBridge's investors include Summit Partners.